Debate on Bacille Calmette-Guerin vaccination against COVID-19: Is it worth performing clinical trials?

ABSTRACT: The non-specific beneficial effects of Bacille Calmette-Guérin (BCG) vaccination suggest that this vaccine might play a role in protecting individuals against severe coronavirus disease 2019 (COVID-19). Several studies propose that BCG vaccination may increase the body's immunity, thereby preventing respiratory infections caused by other respiratory pathogens. As the number of deaths due to COVID-19 is increasing rapidly and there is no specific treatment available to date, scientists are evaluating the effectiveness of already approved drugs as therapies against COVID-19, and the results were found to vary widely: from no significant effect being observed to a reduction in the time taken for clinical improvement. This study thus aims to evaluate whether it is worth performing clinical tri

SUBMITTER: Aziz AB 

PROVIDER: S-EPMC7346814 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature